Free Trial
LON:BXP

Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

Beximco Pharmaceuticals logo
GBX 39.89 -1.11 (-2.71%)
As of 07:17 AM Eastern

About Beximco Pharmaceuticals Stock (LON:BXP)

Key Stats

Today's Range
39
39.89
50-Day Range
34.26
41
52-Week Range
19.33
41
Volume
5,616 shs
Average Volume
51,304 shs
Market Capitalization
£27.19 billion
P/E Ratio
4.28
Dividend Yield
7.52%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BXP Stock News Headlines

I’d rather trade news like this than gamble on hype
Real traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal just triggered a key alert in Tim Sykes’ system… and the setup looks strong.
Annual General Meeting Statement
See More Headlines

BXP Stock Analysis - Frequently Asked Questions

Beximco Pharmaceuticals' stock was trading at GBX 38.20 at the start of the year. Since then, BXP stock has increased by 4.4% and is now trading at GBX 39.89.

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beximco Pharmaceuticals investors own include Advanced Micro Devices (AMD), Bank of America (BAC), Exxon Mobil (XOM), Salesforce (CRM), Chevron (CVX), Meta Platforms (META) and NIKE (NKE).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Trading
Current Symbol
LON:BXP
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 9.32
Trailing P/E Ratio
4.28
Forward P/E Ratio
4.46
P/E Growth
N/A
Net Income
£970.84 billion
Net Margins
13.71%
Pretax Margin
N/A
Return on Equity
13.12%
Return on Assets
6.97%

Debt

Debt-to-Equity Ratio
12.47
Current Ratio
2.13
Quick Ratio
0.37

Sales & Book Value

Annual Sales
£7.08 trillion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
£120.21 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
68,167,060,266
Free Float
N/A
Market Cap
£27.19 billion
Optionable
Not Optionable
Beta
0.61
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:BXP) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners